VIIV-ESS40001

Study Sponsor: ViiV

Study Title

A Phase II, Open-Label, Randomized Study to Compare the Efficacy and Safety of EPIVIR/ZIAGEN/Zerit (3TC/ABC/d4T) Versus EPIVIR/ZIAGEN/Sustiva (3TC/ABC/EFV) Versus EPIVIR/ZIAGEN/GW433908/Norvir (3TC/ABC/908/RTV) for 96 Weeks in the Treatment of HIV-1 Infected Subjects Who are Antiretroviral Thera ...

Medicine or Vaccine (generic name)

fosamprenavir

Sponsor Identification Number

ESS40001

Trial Registry Identification Number(#'s)

N/A

Medical Condition

Infection, Human Immunodeficiency Virus I

Phase

Phase 2

Link to study details on the ViiV Clinical Study Register

https://www.viiv-studyregister.com/study/19793

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies. Due to the age of this study the analysis-ready dataset is not available.

Date Added to this Site

April 2014